Simon Kiddle - Jan 02, 2024
The wonderful potential of waxworm saliva
Enzymes are able to break up plastic, opening the way for rapid recycling.
Sign up to our monthly newsletter to be kept up to date with the latest from the world of IP.
Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023
We are delighted to once again be ranked ‘gold tier’ inIAM PATENT..
Positive feedback on oral proceedings in oppositions carried out by videoconference
In September, the EPO commissioned a survey about their opposition..
Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022
We are delighted to once again be ranked ‘gold tier’ inIAM PATENT..
Mewburn Ellis: top tier firm Legal 500 2022
Seeing Double at the EPO – what was G4/19 actually about?
Whether double patenting, the granting of more than one patent for..
IAM Patent 1000: The World’s Leading Patent Professionals 2021
We are delighted to once again be ranked ‘gold tier’ in IAM PATENT..
Mewburn Ellis: top tier firm Legal 500 2021
We are delighted to be ranked top tier for our patent practice in the..
Oppositions & Appeals: we helped clear a new path to patenting dosage regimes
Case 10 – T 1020/03 (EPO Board of Appeal, 29 October 2004)
This..
A shore thing: eco-friendly seaweed materials
It may be a bother for sunbathers, but seaweed is a promising..
Oppositions & Appeals: novelty of a patient sub-population
Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013)
Novelty of a..
Oppositions & Appeals: we helped determine the meaning of “surgery”
Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011)
We..
IAM Patent 1000: The World’s Leading Patent Professionals 2020
We are delighted to once again be ranked ‘highly recommended’ in ‘IAM..
Oppositions & Appeals: We helped shape the debate on medical use claim patentability
Case 7 – T 879/12 (EPO Board of Appeal, 27 August 2014)
Find out..
Oppositions & Appeals: We moved the conversation on animal involvement
Case 6 – T 1262/04 (EPO Board of Appeal, 13 July 2012)
Should an..
Oppositions & Appeals: We set the standard for the strawman
Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)
In..
Oppositions & Appeals: We made the case for a new technical effect
Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)
The..
Meet The Team: Simon Kiddle, Partner, European Patent Attorney
As part of our 'meet the team' series, we talk to Simon Kiddle about..
IAM Patent 1000, 2019
We are delighted to be ranked highly recommended in ‘IAM 1000: The..
Personalised medicine: patient stratification
While the general idea of customising treatment to patients is not..
Is your interest legitimate? New referral to the EBOA on double patenting
EPO Board of Appeal 3.3.01 is referring a number of questions..